Complications Associated with RSV Infections

Marty J. Feltner, PharmD, provides insights on complications associated with RSV infections and how complications vary for different patient populations.

EP: 1.Overview of RSV Patient Populations

Now Viewing

EP: 2.Complications Associated with RSV Infections

EP: 3.The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV

EP: 4.RSV: Risk Factors and How It’s Spread

EP: 5.Diagnostic Practices for RSV

EP: 6.Increasing Awareness of RSV Vaccines in At-Risk Patients

EP: 7.Shared Decision-Making Practices in RSV

EP: 8.Financial and Clinical Benefits of RSV Immunization

EP: 9.The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59

EP: 10.Addressing Vaccine Fatigue

EP: 11.Identifying Patients Eligible for RSV Vaccine

EP: 12.Current and Potential Obstacles Related to Administering RSV Vaccines

EP: 13.Improving Insurance Coverage for RSV Vaccines

EP: 14.Improving RSV Vaccination Rates and Addressing Misinformation

EP: 15.Key Takeaways on RSV Vaccination

Video content above is prompted by the following questions:

• What complications are associated with RSV infections?
• Do complications differ with age?

Related Videos

Related Content

Advertisement

October 21st 2024

Clinical Outcomes, Mortality Risk Factor of RSV, Influenza in Hospitalized Adults

Pearl Steinzor

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or influenza across Europe.

October 9th 2024

Identifying Post-Discharge Care Needs Among Adults Hospitalized with RSV

Pearl Steinzor

Study compares immediate post-discharge care requirements for respiratory syncytial virus (RSV), influenza, acute myocardial infarction, and stroke.

October 4th 2024

Adult RSV Hospitalizations: Clinical Characteristics, Risk Factors for Severe Outcomes

Pearl Steinzor

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV) receiving care through the emergency department.

September 30th 2024

Vaccine Hesitancy Persists Despite Understanding Vaccination Effectiveness, Survey Finds

Pearl Steinzor

Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.

September 27th 2024

Ziresovir Reduces Bronchiolitis in Infants Hospitalized With RSV

Pearl Steinzor

Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants, offering hope for an effective treatment.

September 26th 2024

RSV Vaccines Effective in Older Adults in Long-Term Care Facilities

Julia Bonavitacola

A robust antibody response was found in patients in residents of long-term care facilities who were given the respiratory syncytial virus (RSV) vaccine.

Related Content

Advertisement

October 21st 2024

Clinical Outcomes, Mortality Risk Factor of RSV, Influenza in Hospitalized Adults

Pearl Steinzor

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or influenza across Europe.

October 9th 2024

Identifying Post-Discharge Care Needs Among Adults Hospitalized with RSV

Pearl Steinzor

Study compares immediate post-discharge care requirements for respiratory syncytial virus (RSV), influenza, acute myocardial infarction, and stroke.

October 4th 2024

Adult RSV Hospitalizations: Clinical Characteristics, Risk Factors for Severe Outcomes

Pearl Steinzor

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV) receiving care through the emergency department.

September 30th 2024

Vaccine Hesitancy Persists Despite Understanding Vaccination Effectiveness, Survey Finds

Pearl Steinzor

Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.

September 27th 2024

Ziresovir Reduces Bronchiolitis in Infants Hospitalized With RSV

Pearl Steinzor

Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants, offering hope for an effective treatment.

September 26th 2024

RSV Vaccines Effective in Older Adults in Long-Term Care Facilities

Julia Bonavitacola

A robust antibody response was found in patients in residents of long-term care facilities who were given the respiratory syncytial virus (RSV) vaccine.